A recent study using B-cell lymphoma cell lines and primary CLL cells demonstrated that CpG island methylation within the PUMA promoter after venetoclax treatment downregulates PUMA expression at both the transcript and protein levels [58]. Here, BBC3 is linked to B-cell chronic lymphocytic leukemia.